Business UpdateJun 2, 2026, 07:41 AM
Quantum BioPharma Engages IR Agency for $250,000 Investor Relations
AI Summary
Quantum BioPharma Ltd. has entered into a 6-month investor relations and consulting services agreement with Stocks.news through IR Agency LLC, effective June 8, 2026. The company will pay a fee of US$250,000 for services including creating company profiles, media distribution, digital community building, marketing, and lead generation. The agency is an arm's-length party and does not hold any equity interest in Quantum BioPharma.
Key Highlights
- Quantum BioPharma engaged IR Agency LLC for investor relations and consulting services.
- The agreement is for a 6-month period, starting June 8, 2026.
- The total fee for the services is US$250,000.
- IR Agency will provide company profiles, media distribution, and lead generation.
- The agency is arm's-length and holds no equity interest in Quantum BioPharma.
- Quantum retains 19.84% ownership in Unbuzzd Wellness Inc. as of March 31, 2026.
- Quantum receives a 7% royalty on Unbuzzd sales until $250 million, then 3% perpetually.
Price Impact
More from QNTM